GenesisCare: MDT discussions

Independent sector MDTs provide a clinically governed route for timely specialist review outside traditional NHS hosted meetings.

GenesisCare delivers a structured, well governed independent sector MDT service. Delivered through a secure digital platform with defined membership, standardised referrals and auditable outcomes, they provide access to specialist opinion, support consistent treatment planning and strengthen collaboration. The model supports asynchronous and live meetings, enabling timely specialist input, flexible clinician participation and continuity of care. MDTs are coordinated by dedicated MDT Clinical Coordinators who facilitate meetings and support members and referrers with case preparation.

Each MDT uses a tumour-specific proforma designed in collaboration with the relevant Clinical Reference Group. It captures the information needed for safe recommendations, including demographics, clinical summary, diagnostics and the referral question or proposed treatment pathway for discussion. Patient consent is recorded by the referrer, supporting governance and UK GDPR compliance. This also ensures that patients are aware of MDT discussion and the use, storage, and sharing of their data.

Each MDT is presented for discussion with a defined minimum dataset, promoting consistency, reducing incomplete reviews and keeping discussion focused on the referral question, treatment options and next steps.

MDT discussions produce a documented collective consensus to guide the most appropriate treatment pathway. Outcomes are captured in a structured report, including the recommended management plan, dataset reviewed and member opinions, creating a clear audit trail for the referrer.

GenesisCare supports robust clinical governance and continuous improvement through routine collection of auditable MDT data. This enables oversight through Committee reporting of activity, outcome monitoring, review of consistency and effectiveness, identification of improvement opportunities and assurance of safe, high-quality care.

For referring clinicians, it provides a clear route for review, documented outcomes and confidence in structured governance. For the wider system, independent sector MDTs can add capacity, support partnership working and provide auditable evidence of quality, safety and value.